Conventional MRI radiomics in patients with suspected early- or pseudo-progression.
Alexandre Bani SadrOmer Faruk EkerLise-Prune BernerRoxana AmeliMarc HermierMarc BarritaultDavid MeyronetJacques GuyotatEmmanuel JouanneauJerome HonnoratFrançois DucrayYves BerthezenePublished in: Neuro-oncology advances (2019)
Conventional MRI radiomics has promising diagnostic value, especially when combined with MGMT promoter status, but with moderate specificity. In addition, our results suggest a potential for predicting OS and PFS.